Dimensional Fund Advisors
APTO

Dimensional Fund Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Dimensional Fund Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-152
Closed -$41K – 3532
2022
Q3 		$41K Hold
152
– – ﹤0.01% 3428
2022
Q2 		$51K Hold
152
– – ﹤0.01% 3386
2022
Q1 		$93K Hold
152
– – ﹤0.01% 3400
2021
Q4 		$92K Hold
152
– – ﹤0.01% 3446
2021
Q3 		$149K Buy
+152
New +$190K ﹤0.01% 3383

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Dimensional Fund Advisors's APTO Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q4 2022, closing a stake of 152 shares — an estimated $41K sold.

Dimensional Fund Advisors first reported a position in APTO in Q3 2021 and held it in 5 quarters. The position peaked at $149K in Q3 2021. 47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining Aptose Biosciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 152 Aptose Biosciences, Inc. shares in Q4 2022, an estimated $41K.
  • Dimensional Fund Advisors first reported a position in Aptose Biosciences, Inc. in Q3 2021 and held it in 5 quarters.
  • Dimensional Fund Advisors's Aptose Biosciences, Inc. position peaked at $149K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.